Healthcare provider profile · identity verified

Peter S. Justis, MD

Internal Medicine · CHARLOTTE, NC · NPI 1205856499

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1507	402
Amlodipine Besylate	Amlodipine Besylate	926	264
Levothyroxine Sodium	Levothyroxine Sodium	627	141
Hydrochlorothiazide	Hydrochlorothiazide	476	139
Losartan Potassium	Losartan Potassium	468	126
Omeprazole	Omeprazole	418	113
Rosuvastatin Calcium	Rosuvastatin Calcium	375	112
Lisinopril	Lisinopril	342	88
Sertraline Hcl	Sertraline Hcl	288	75
Simvastatin	Simvastatin	287	81
Metoprolol Succinate	Metoprolol Succinate	285	80
Tamsulosin Hcl	Tamsulosin Hcl	281	82
Pantoprazole Sodium	Pantoprazole Sodium	279	80
Gabapentin	Gabapentin	248	71
Metformin Hcl	Metformin Hcl	242	70
Fluticasone Propionate	Fluticasone Propionate	209	63
Pravastatin Sodium	Pravastatin Sodium	203	59
Eliquis	Apixaban	190	37
Trazodone Hcl	Trazodone Hcl	190	54
Metformin Hcl Er	Metformin Hcl	177	49
Furosemide	Furosemide	175	64
Potassium Chloride	Potassium Chloride	165	54
Meloxicam	Meloxicam	164	55
Ramipril	Ramipril	139	39
Allopurinol	Allopurinol	126	34
Alprazolam	Alprazolam	123	40
Clonidine Hcl	Clonidine Hcl	119	32
Metoprolol Tartrate	Metoprolol Tartrate	116	33
Finasteride	Finasteride	113	31
Zolpidem Tartrate	Zolpidem Tartrate	111	27
Synthroid	Levothyroxine Sodium	108	25
Alendronate Sodium	Alendronate Sodium	105	30
Clonazepam	Clonazepam	105	19
Citalopram Hbr	Citalopram Hydrobromide	102	28
Warfarin Sodium	Warfarin Sodium	99	23
Duloxetine Hcl	Duloxetine Hcl	95	27
Januvia	Sitagliptin Phosphate	92	19
Doxazosin Mesylate	Doxazosin Mesylate	88	26
Lorazepam	Lorazepam	88	20
Carvedilol	Carvedilol	85	29
Albuterol Sulfate Hfa	Albuterol Sulfate	84	22
Montelukast Sodium	Montelukast Sodium	83	28
Ezetimibe	Ezetimibe	80	31
Benazepril Hcl	Benazepril Hcl	78	23
Famotidine	Famotidine	78	25
Jardiance	Empagliflozin	77	16
Buspirone Hcl	Buspirone Hcl	73	22
Escitalopram Oxalate	Escitalopram Oxalate	73	28
Celecoxib	Celecoxib	71	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	17
Ozempic	Semaglutide	70	15
Prednisone	Prednisone	68	56
Bupropion Xl	Bupropion Hcl	65	18
Atenolol	Atenolol	63	17
Fluoxetine Hcl	Fluoxetine Hcl	63	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	14
Glipizide Er	Glipizide	57	14
Propranolol Hcl	Propranolol Hcl	55	13
Clopidogrel	Clopidogrel Bisulfate	54	17
Mirtazapine	Mirtazapine	52	15
Nifedipine Er	Nifedipine	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Donepezil Hcl	Donepezil Hcl	49	12
Xarelto	Rivaroxaban	49	12
Hydralazine Hcl	Hydralazine Hcl	47	15
Ipratropium Bromide	Ipratropium Bromide	46	19
Doxycycline Hyclate	Doxycycline Hyclate	43	42
Valsartan	Valsartan	43	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	12
Esomeprazole Magnesium	Esomeprazole Magnesium	41	12
Mounjaro	Tirzepatide	41	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	40	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	32
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Spironolactone	Spironolactone	38	12
Valacyclovir	Valacyclovir Hcl	37	14
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Primidone	Primidone	34	suppressed
Estradiol	Estradiol	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Diazepam	Diazepam	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	18
Amoxicillin	Amoxicillin	29	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Baclofen	Baclofen	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	16
Farxiga	Dapagliflozin Propanediol	26	suppressed
Glipizide	Glipizide	26	suppressed
Klor-Con M10	Potassium Chloride	26	13
Tramadol Hcl	Tramadol Hcl	26	11
Hydrocortisone	Hydrocortisone	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	22	22
Cephalexin	Cephalexin	22	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Minoxidil	Minoxidil	19	suppressed
Colchicine	Colchicine	18	suppressed
Gemtesa	Vibegron	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	16
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Euthyrox	Levothyroxine Sodium	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Linzess	Linaclotide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Toprol Xl	Metoprolol Succinate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Febuxostat	Febuxostat	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Repatha Syringe	Evolocumab	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Atacand	Candesartan Cilexetil	12	suppressed
Azithromycin	Azithromycin	12	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Alprazolam Er	Alprazolam	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Topiramate	Topiramate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error